FDA.reportPublic FDA data

24 HR amphetamine 18.8 MG Extended Release Oral Tablet [Adzenys]

RxCUI
1739821
RxNorm name
24 HR amphetamine 18.8 MG Extended Release Oral Tablet [Adzenys]
Display name
24 HR amphetamine 18.8 MG Extended Release Oral Tablet [Adzenys]
Full name
24 HR amphetamine 18.8 MG Extended Release Oral Tablet [Adzenys]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Adzenys XR-ODTAMPHETAMINENeos Therapeutics Brands, LLCc1179269-00b5-48ea-972d-31e614e99b7e2026-05-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1739821

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c1179269-00b5-48ea-972d-31e614e99b7eAdzenys XR-ODT 18.8 MG 24HR Extended Release Distintegrating Oral Tablet [PSN] · 24 HR amphetamine 18.8 MG Extended Release Oral Tablet [Adzenys] [SBD] · Adzenys 18.8 MG 24 HR Extended Release Distintegrating Oral Tablet [SY]315These highlights do not include all the information needed to use ADZENYS XR-ODT™ safely and effectively. See full prescribing information for ADZENYS XR-ODT. ADZENYS XR-ODT (amphetamine) extended-release orally disintegrating tablets, CII Initial U.S. Approval: 196020260506